TY - JOUR
T1 - A case of high-frequency microsatellite instability in colorectal cancer with MSH2 mutation detected using gene panel testing with a next-generation sequencer
AU - Shimada, Yoshifumi
AU - Kameyama, Hitoshi
AU - Nakano, Mae
AU - Toshikawa, Chie
AU - Moro, Kazuki
AU - Tsuchida, Junko
AU - Arabiki, Michiru
AU - Matsumoto, Akio
AU - Tanaka, Kana
AU - Abe, Kaoru
AU - Oyanagi, Hidehito
AU - Tajima, Yosuke
AU - Nakano, Masato
AU - Hirose, Yuki
AU - Kano, Yosuke
AU - Ichikawa, Hiroshi
AU - Hanyu, Takaaki
AU - Takizawa, Kazuyasu
AU - Nagahashi, Masayuki
AU - Sakata, Jun
AU - Wakai, Toshifumi
N1 - Publisher Copyright:
© 2020 Japanese Journal of Cancer and Chemotherapy Publishers Inc.. All rights reserved.
PY - 2020/7
Y1 - 2020/7
N2 - Here, we report about a woman in her 30s who had peritoneal dissemination and multiple colon cancer with high-frequency microsatellite instability (MSI-H). Her father, paternal grandfather, and maternal grandmother had a history of colorectal cancer treatment. Thus, Lynch syndrome was suspected. We performed R0 resection for peritoneal dissemination and subsequent peritoneal dissemination. A 435-gene panel testing using a next-generation sequencer identified MSH2 and other mutations in the tumor. Hence, we speculated that she could have a germline mutation of MSH2, which causes Lynch syndrome. In the future, if she wishes to receive genetic counseling and undergo germline testing for variants to confirm the diagnosis of Lynch syndrome, we will perform them after receiving informed consent.
AB - Here, we report about a woman in her 30s who had peritoneal dissemination and multiple colon cancer with high-frequency microsatellite instability (MSI-H). Her father, paternal grandfather, and maternal grandmother had a history of colorectal cancer treatment. Thus, Lynch syndrome was suspected. We performed R0 resection for peritoneal dissemination and subsequent peritoneal dissemination. A 435-gene panel testing using a next-generation sequencer identified MSH2 and other mutations in the tumor. Hence, we speculated that she could have a germline mutation of MSH2, which causes Lynch syndrome. In the future, if she wishes to receive genetic counseling and undergo germline testing for variants to confirm the diagnosis of Lynch syndrome, we will perform them after receiving informed consent.
UR - http://www.scopus.com/inward/record.url?scp=85088156774&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088156774&partnerID=8YFLogxK
M3 - Article
C2 - 32668864
AN - SCOPUS:85088156774
SN - 0385-0684
VL - 47
SP - 1113
EP - 1115
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 7
ER -